ag-946
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 10, 2020 (NCT04536792)
Timeline
Indications
Mechanism of action
- Pyruvate kinase isozymes R/LACTIVATOR
PKLR activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05490446 | Phase 2 | Oct 20, 2022 | Agios Pharmaceuticals, Inc. |
| NCT04536792 | Phase 1 | Jul 10, 2020 | Agios Pharmaceuticals, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Agios Pharmaceuticals, Inc. | For profit | 2 | 2 | 2 | 2020 |
1 organizations
Page 1 / 1